Zobrazeno 1 - 1
of 1
pro vyhledávání: ''
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Objectives: Non-alcoholic fatty liver disease (NAFLD) and its progression to non-alcoholic steatohepatitis (NASH) and hepatocarcinoma is a serious and growing problem. However, the development of new therapies is severely hindered by a lack of high-t
Externí odkaz:
https://doaj.org/article/dca278fd60ba4901964c68bc8ba6004c